BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260819
DTEND;VALUE=DATE:20260822
DTSTAMP:20260515T004907
CREATED:20260430T095421Z
LAST-MODIFIED:20260430T095421Z
UID:43423-1787097600-1787356799@www.pharmajournalist.com
SUMMARY:6th Oligonucleotides for CNS Summit
DESCRIPTION:The 6th Annual Oligonucleotides for CNS Summit USA returns to Boston on 19–21 August 2026\, uniting 160+ leaders across pharma and biotech to accelerate the discovery\, translation and clinical success of CNS‑targeted oligonucleotide therapies. As advances in RNA chemistry\, delivery technologies and clinical evidence unlock previously undruggable CNS targets\, this meeting is the industry’s most focused forum to benchmark what is truly working — and what’s next. \nAcross three highly interactive days\, hear the latest data and strategy from companies including Eli Lilly\, Stoke Therapeutics\, Dyne Therapeutics\, Creyon Bio and Quiver Bioscience\, covering ASOs\, siRNAs\, saRNAs and aptamers. Dive into real‑world challenges around CNS penetration\, BBB shuttles\, intrathecal vs systemic delivery\, splice modulation\, chemistry and conjugation design\, PK/PD translation\, safety and regulatory alignment — all through case studies\, panels\, workshops and roundtables designed for open\, precompetitive discussion. \nWith expanding pipelines\, growing competition and rising expectations for clinical impact beyond rare disease\, this summit offers a uniquely concentrated environment to learn from clinical‑stage programs\, stress‑test your development strategy and connect with the scientists and decision‑makers shaping the future of CNS oligonucleotides. \nFind out more today – https://ter.li/twgv2av6
URL:https://www.pharmajournalist.com/event/6th-oligonucleotides-for-cns-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR